These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

411 related items for PubMed ID: 31256613

  • 1. Microperimetric changes and fixation stability status after half-dose photodynamic therapy for chronic central serous chorioretinopathy.
    Gulkas S, Sahin O.
    Eur J Ophthalmol; 2020 Sep; 30(5):1053-1060. PubMed ID: 31256613
    [Abstract] [Full Text] [Related]

  • 2. COMPARISON OF PHOTODYNAMIC THERAPY USING HALF-DOSE OF VERTEPORFIN OR HALF-FLUENCE OF LASER LIGHT FOR THE TREATMENT OF CHRONIC CENTRAL SEROUS CHORIORETINOPATHY.
    Cheng CK, Chang CK, Peng CH.
    Retina; 2017 Feb; 37(2):325-333. PubMed ID: 27429374
    [Abstract] [Full Text] [Related]

  • 3. Microperimetric changes after photodynamic therapy for central serous chorioretinopathy.
    Senturk F, Karacorlu M, Ozdemir H, Karacorlu SA, Uysal O.
    Am J Ophthalmol; 2011 Feb; 151(2):303-9.e1. PubMed ID: 21168824
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Half-fluence photodynamic therapy in chronic central serous chorioretinopathy.
    Smretschnig E, Ansari-Shahrezaei S, Hagen S, Glittenberg C, Krebs I, Binder S.
    Retina; 2013 Feb; 33(2):316-23. PubMed ID: 23314238
    [Abstract] [Full Text] [Related]

  • 6. Comparison of Focal and Conventional Verteporfin Photodynamic Therapy for Chronic Central Serous Chorioretinopathy.
    Noh SR, Kang MS, Kim K, Kim ES, Yu SY.
    Korean J Ophthalmol; 2019 Dec; 33(6):506-513. PubMed ID: 31833247
    [Abstract] [Full Text] [Related]

  • 7. Photodynamic therapy for chronic central serous chorioretinopathy: a 4-year follow-up study.
    Silva RM, Ruiz-Moreno JM, Gomez-Ulla F, Montero JA, Gregório T, Cachulo ML, Pires IA, Cunha-Vaz JG, Murta JN.
    Retina; 2013 Feb; 33(2):309-15. PubMed ID: 23095766
    [Abstract] [Full Text] [Related]

  • 8. Functional retinal changes measured by microperimetry in standard-fluence vs low-fluence photodynamic therapy in chronic central serous chorioretinopathy.
    Reibaldi M, Boscia F, Avitabile T, Uva MG, Russo A, Zagari M, Occhipinti F, Russo V, Reibaldi A, Longo A.
    Am J Ophthalmol; 2011 Jun; 151(6):953-960.e2. PubMed ID: 21457929
    [Abstract] [Full Text] [Related]

  • 9. Long-term chorioretinal changes after photodynamic therapy for chronic central serous chorioretinopathy.
    Vasconcelos H, Marques I, Santos AR, Melo P, Pires I, Figueira J, de Abreu JF, Cachulo ML, Silva R.
    Graefes Arch Clin Exp Ophthalmol; 2013 Jul; 251(7):1697-705. PubMed ID: 23389551
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Morphological and Functional Changes Immediately After Half-Time Photodynamic Therapy in Patients With Central Serous Chorioretinopathy.
    Muslubas IS, Ersoz MG, Hocaoglu M, Arf S, Karacorlu M.
    Ophthalmic Surg Lasers Imaging Retina; 2018 Dec 01; 49(12):932-940. PubMed ID: 30566700
    [Abstract] [Full Text] [Related]

  • 14. One-year choroidal thickness results after photodynamic therapy for central serous chorioretinopathy.
    Maruko I, Iida T, Sugano Y, Furuta M, Sekiryu T.
    Retina; 2011 Oct 01; 31(9):1921-7. PubMed ID: 21878850
    [Abstract] [Full Text] [Related]

  • 15. Comparison between the outcomes of fluorescein angiography-guided and indocyanine green angiography-guided half-time photodynamic therapy for central serous chorioretinopathy.
    Hayashida M, Miki A, Honda S, Nakamura M.
    Photodiagnosis Photodyn Ther; 2020 Sep 01; 31():101955. PubMed ID: 32818640
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Long-Term Efficacy and Safety of Photodynamic Therapy in Patients With Chronic Central Serous Chorioretinopathy.
    Park YJ, Kim YK, Park KH, Woo SJ.
    Ophthalmic Surg Lasers Imaging Retina; 2019 Dec 01; 50(12):760-770. PubMed ID: 31877221
    [Abstract] [Full Text] [Related]

  • 19. RESPONSE OF CHOROIDAL ABNORMALITIES TO PHOTODYNAMIC THERAPY VERSUS MICROPULSE LASER IN CHRONIC CENTRAL SEROUS CHORIORETINOPATHY: Place Trial Report No. 4.
    van Rijssen TJ, Hahn LC, van Dijk EHC, Tsonaka R, Scholz P, Breukink MB, Blanco-Garavito R, Souied EH, Keunen JEE, MacLaren RE, Querques G, Fauser S, Downes SM, Hoyng CB, Boon CJF.
    Retina; 2021 Oct 01; 41(10):2122-2131. PubMed ID: 34543244
    [Abstract] [Full Text] [Related]

  • 20. Long-Term Effects of Half-Time Photodynamic Therapy on Retinal Sensitivity in Eyes with Chronic Central Serous Chorioretinopathy.
    Iwase T, Yokouchi H, Kitahashi M, Kubota-Taniai M, Baba T, Yamamoto S.
    Biomed Res Int; 2020 Oct 01; 2020():3190136. PubMed ID: 32908883
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.